aluates Reports

$ 0.0

Automative

Global PROTAC Technology Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-33V17275

Global PROTAC Technology Market Research Report 2024

BUY CHAPTERS

Global PROTAC Technology Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33V17275

Report

October 2025

Pages:150

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Arvinas Inc

Captor therapeutics

Pfizer Inc

Amgen Inc

Oerth Bio

Bayer

Kymera

Nurix

C4 Therapeutics, Inc.

Astellas Pharma Inc

AbbVie

Kaituo Pharmaceutical

Betta Pharmaceuticals

Hengrui Medicine

BeiGene Ltd

Haichuang Pharmaceutical

East China Pharmaceutical Group

PROTAC Technology Market

The global PROTAC Technology market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

As a new type of small molecule drug development technology, PROTAC is receiving more and more attention. Major pharmaceutical companies and biotechnology companies have invested heavily in research and development in the hope of making breakthroughs in this field. With the continuous advancement of technology and the accumulation of clinical data, PROTAC is expected to achieve more breakthroughs in the next few years and provide more possibilities for the development of new drugs.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global PROTAC Technology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of PROTAC Technology Market Report

Report Metric	Details
Report Name	PROTAC Technology Market
Segment by Type	Based on CRBN Based on VHL
Segment by Application	Breast Cancer Prostate Cancer Colorectal Cancer Pancreatic Cancer Lymphoma Androgenic Alopecia Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix, C4 Therapeutics, Inc., Astellas Pharma Inc., AbbVie, Kaituo Pharmaceutical, Betta Pharmaceuticals, Hengrui Medicine, BeiGene, Haichuang Pharmaceutical, East China Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the PROTAC Technology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the PROTAC Technology Market report?

Ans: The main players in the PROTAC Technology Market are Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix, C4 Therapeutics, Inc., Astellas Pharma Inc., AbbVie, Kaituo Pharmaceutical, Betta Pharmaceuticals, Hengrui Medicine, BeiGene, Haichuang Pharmaceutical, East China Pharmaceutical Group

What are the Application segmentation covered in the PROTAC Technology Market report?

Ans: The Applications covered in the PROTAC Technology Market report are Breast Cancer, Prostate Cancer, Colorectal Cancer, Pancreatic Cancer, Lymphoma, Androgenic Alopecia, Others

What are the Type segmentation covered in the PROTAC Technology Market report?

Ans: The Types covered in the PROTAC Technology Market report are Based on CRBN, Based on VHL

Recommended Reports

Oncology Drug Markets

Cancer Diagnostics Therapy

Pharma Technology Trends

1 Study Coverage

1.1 Introduction to PROTAC Technology: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global PROTAC Technology Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Based on CRBN

1.2.3 Based on VHL

1.3 Market Segmentation by Application

1.3.1 Global PROTAC Technology Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.3.4 Colorectal Cancer

1.3.5 Pancreatic Cancer

1.3.6 Lymphoma

1.3.7 Androgenic Alopecia

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global PROTAC Technology Revenue Estimates and Forecasts 2020-2031

2.2 Global PROTAC Technology Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global PROTAC Technology Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global PROTAC Technology Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Based on CRBN Market Size by Players

3.3.2 Based on VHL Market Size by Players

3.4 Global PROTAC Technology Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global PROTAC Technology Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global PROTAC Technology Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America PROTAC Technology Market Size by Type (2020-2031)

6.4 North America PROTAC Technology Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America PROTAC Technology Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe PROTAC Technology Market Size by Type (2020-2031)

7.4 Europe PROTAC Technology Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe PROTAC Technology Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific PROTAC Technology Market Size by Type (2020-2031)

8.4 Asia-Pacific PROTAC Technology Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific PROTAC Technology Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America PROTAC Technology Market Size by Type (2020-2031)

9.4 Central and South America PROTAC Technology Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America PROTAC Technology Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa PROTAC Technology Market Size by Type (2020-2031)

10.4 Middle East and Africa PROTAC Technology Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa PROTAC Technology Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Arvinas

11.1.1 Arvinas Corporation Information

11.1.2 Arvinas Business Overview

11.1.3 Arvinas PROTAC Technology Product Features and Attributes

11.1.4 Arvinas PROTAC Technology Revenue and Gross Margin (2020-2025)

11.1.5 Arvinas PROTAC Technology Revenue by Product in 2024

11.1.6 Arvinas PROTAC Technology Revenue by Application in 2024

11.1.7 Arvinas PROTAC Technology Revenue by Geographic Area in 2024

11.1.8 Arvinas PROTAC Technology SWOT Analysis

11.1.9 Arvinas Recent Developments

11.2 Captor therapeutics

11.2.1 Captor therapeutics Corporation Information

11.2.2 Captor therapeutics Business Overview

11.2.3 Captor therapeutics PROTAC Technology Product Features and Attributes

11.2.4 Captor therapeutics PROTAC Technology Revenue and Gross Margin (2020-2025)

11.2.5 Captor therapeutics PROTAC Technology Revenue by Product in 2024

11.2.6 Captor therapeutics PROTAC Technology Revenue by Application in 2024

11.2.7 Captor therapeutics PROTAC Technology Revenue by Geographic Area in 2024

11.2.8 Captor therapeutics PROTAC Technology SWOT Analysis

11.2.9 Captor therapeutics Recent Developments

11.3 Pfizer

11.3.1 Pfizer Corporation Information

11.3.2 Pfizer Business Overview

11.3.3 Pfizer PROTAC Technology Product Features and Attributes

11.3.4 Pfizer PROTAC Technology Revenue and Gross Margin (2020-2025)

11.3.5 Pfizer PROTAC Technology Revenue by Product in 2024

11.3.6 Pfizer PROTAC Technology Revenue by Application in 2024

11.3.7 Pfizer PROTAC Technology Revenue by Geographic Area in 2024

11.3.8 Pfizer PROTAC Technology SWOT Analysis

11.3.9 Pfizer Recent Developments

11.4 Amgen

11.4.1 Amgen Corporation Information

11.4.2 Amgen Business Overview

11.4.3 Amgen PROTAC Technology Product Features and Attributes

11.4.4 Amgen PROTAC Technology Revenue and Gross Margin (2020-2025)

11.4.5 Amgen PROTAC Technology Revenue by Product in 2024

11.4.6 Amgen PROTAC Technology Revenue by Application in 2024

11.4.7 Amgen PROTAC Technology Revenue by Geographic Area in 2024

11.4.8 Amgen PROTAC Technology SWOT Analysis

11.4.9 Amgen Recent Developments

11.5 Oerth Bio

11.5.1 Oerth Bio Corporation Information

11.5.2 Oerth Bio Business Overview

11.5.3 Oerth Bio PROTAC Technology Product Features and Attributes

11.5.4 Oerth Bio PROTAC Technology Revenue and Gross Margin (2020-2025)

11.5.5 Oerth Bio PROTAC Technology Revenue by Product in 2024

11.5.6 Oerth Bio PROTAC Technology Revenue by Application in 2024

11.5.7 Oerth Bio PROTAC Technology Revenue by Geographic Area in 2024

11.5.8 Oerth Bio PROTAC Technology SWOT Analysis

11.5.9 Oerth Bio Recent Developments

11.6 Bayer

11.6.1 Bayer Corporation Information

11.6.2 Bayer Business Overview

11.6.3 Bayer PROTAC Technology Product Features and Attributes

11.6.4 Bayer PROTAC Technology Revenue and Gross Margin (2020-2025)

11.6.5 Bayer Recent Developments

11.7 Kymera

11.7.1 Kymera Corporation Information

11.7.2 Kymera Business Overview

11.7.3 Kymera PROTAC Technology Product Features and Attributes

11.7.4 Kymera PROTAC Technology Revenue and Gross Margin (2020-2025)

11.7.5 Kymera Recent Developments

11.8 Nurix

11.8.1 Nurix Corporation Information

11.8.2 Nurix Business Overview

11.8.3 Nurix PROTAC Technology Product Features and Attributes

11.8.4 Nurix PROTAC Technology Revenue and Gross Margin (2020-2025)

11.8.5 Nurix Recent Developments

11.9 C4 Therapeutics, Inc.

11.9.1 C4 Therapeutics, Inc. Corporation Information

11.9.2 C4 Therapeutics, Inc. Business Overview

11.9.3 C4 Therapeutics, Inc. PROTAC Technology Product Features and Attributes

11.9.4 C4 Therapeutics, Inc. PROTAC Technology Revenue and Gross Margin (2020-2025)

11.9.5 C4 Therapeutics, Inc. Recent Developments

11.10 Astellas Pharma Inc.

11.10.1 Astellas Pharma Inc. Corporation Information

11.10.2 Astellas Pharma Inc. Business Overview

11.10.3 Astellas Pharma Inc. PROTAC Technology Product Features and Attributes

11.10.4 Astellas Pharma Inc. PROTAC Technology Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 AbbVie

11.11.1 AbbVie Corporation Information

11.11.2 AbbVie Business Overview

11.11.3 AbbVie PROTAC Technology Product Features and Attributes

11.11.4 AbbVie PROTAC Technology Revenue and Gross Margin (2020-2025)

11.11.5 AbbVie Recent Developments

11.12 Kaituo Pharmaceutical

11.12.1 Kaituo Pharmaceutical Corporation Information

11.12.2 Kaituo Pharmaceutical Business Overview

11.12.3 Kaituo Pharmaceutical PROTAC Technology Product Features and Attributes

11.12.4 Kaituo Pharmaceutical PROTAC Technology Revenue and Gross Margin (2020-2025)

11.12.5 Kaituo Pharmaceutical Recent Developments

11.13 Betta Pharmaceuticals

11.13.1 Betta Pharmaceuticals Corporation Information

11.13.2 Betta Pharmaceuticals Business Overview

11.13.3 Betta Pharmaceuticals PROTAC Technology Product Features and Attributes

11.13.4 Betta Pharmaceuticals PROTAC Technology Revenue and Gross Margin (2020-2025)

11.13.5 Betta Pharmaceuticals Recent Developments

11.14 Hengrui Medicine

11.14.1 Hengrui Medicine Corporation Information

11.14.2 Hengrui Medicine Business Overview

11.14.3 Hengrui Medicine PROTAC Technology Product Features and Attributes

11.14.4 Hengrui Medicine PROTAC Technology Revenue and Gross Margin (2020-2025)

11.14.5 Hengrui Medicine Recent Developments

11.15 BeiGene

11.15.1 BeiGene Corporation Information

11.15.2 BeiGene Business Overview

11.15.3 BeiGene PROTAC Technology Product Features and Attributes

11.15.4 BeiGene PROTAC Technology Revenue and Gross Margin (2020-2025)

11.15.5 BeiGene Recent Developments

11.16 Haichuang Pharmaceutical

11.16.1 Haichuang Pharmaceutical Corporation Information

11.16.2 Haichuang Pharmaceutical Business Overview

11.16.3 Haichuang Pharmaceutical PROTAC Technology Product Features and Attributes

11.16.4 Haichuang Pharmaceutical PROTAC Technology Revenue and Gross Margin (2020-2025)

11.16.5 Haichuang Pharmaceutical Recent Developments

11.17 East China Pharmaceutical Group

11.17.1 East China Pharmaceutical Group Corporation Information

11.17.2 East China Pharmaceutical Group Business Overview

11.17.3 East China Pharmaceutical Group PROTAC Technology Product Features and Attributes

11.17.4 East China Pharmaceutical Group PROTAC Technology Revenue and Gross Margin (2020-2025)

11.17.5 East China Pharmaceutical Group Recent Developments

12 PROTAC TechnologyIndustry Chain Analysis

12.1 PROTAC Technology Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 PROTAC Technology Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global PROTAC Technology Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Arvinas Inc

Captor therapeutics

Pfizer Inc

Amgen Inc

Oerth Bio

Bayer

Kymera

Nurix

C4 Therapeutics, Inc.

Astellas Pharma Inc

AbbVie

Kaituo Pharmaceutical

Betta Pharmaceuticals

Hengrui Medicine

BeiGene Ltd

Haichuang Pharmaceutical

East China Pharmaceutical Group

List of Tables

Table 1. Global PROTAC Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global PROTAC Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global PROTAC Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global PROTAC Technology Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global PROTAC Technology Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global PROTAC Technology Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global PROTAC Technology Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global PROTAC Technology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PROTAC Technology as of 2024)

Table 11. Global PROTAC Technology Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global PROTAC Technology Companies Headquarters

Table 13. Global PROTAC Technology Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global PROTAC Technology Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global PROTAC Technology Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global PROTAC Technology Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global PROTAC Technology Revenue by Application (2026-2031) & (US$ Million)

Table 21. PROTAC Technology High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America PROTAC Technology Growth Accelerators and Market Barriers

Table 25. North America PROTAC Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe PROTAC Technology Growth Accelerators and Market Barriers

Table 27. Europe PROTAC Technology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific PROTAC Technology Growth Accelerators and Market Barriers

Table 29. Asia-Pacific PROTAC Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America PROTAC Technology Investment Opportunities and Key Challenges

Table 31. Central and South America PROTAC Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa PROTAC Technology Investment Opportunities and Key Challenges

Table 33. Middle East and Africa PROTAC Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Arvinas Corporation Information

Table 35. Arvinas Description and Major Businesses

Table 36. Arvinas Product Features and Attributes

Table 37. Arvinas Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Arvinas Revenue Proportion by Product in 2024

Table 39. Arvinas Revenue Proportion by Application in 2024

Table 40. Arvinas Revenue Proportion by Geographic Area in 2024

Table 41. Arvinas PROTAC Technology SWOT Analysis

Table 42. Arvinas Recent Developments

Table 43. Captor therapeutics Corporation Information

Table 44. Captor therapeutics Description and Major Businesses

Table 45. Captor therapeutics Product Features and Attributes

Table 46. Captor therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Captor therapeutics Revenue Proportion by Product in 2024

Table 48. Captor therapeutics Revenue Proportion by Application in 2024

Table 49. Captor therapeutics Revenue Proportion by Geographic Area in 2024

Table 50. Captor therapeutics PROTAC Technology SWOT Analysis

Table 51. Captor therapeutics Recent Developments

Table 52. Pfizer Corporation Information

Table 53. Pfizer Description and Major Businesses

Table 54. Pfizer Product Features and Attributes

Table 55. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Pfizer Revenue Proportion by Product in 2024

Table 57. Pfizer Revenue Proportion by Application in 2024

Table 58. Pfizer Revenue Proportion by Geographic Area in 2024

Table 59. Pfizer PROTAC Technology SWOT Analysis

Table 60. Pfizer Recent Developments

Table 61. Amgen Corporation Information

Table 62. Amgen Description and Major Businesses

Table 63. Amgen Product Features and Attributes

Table 64. Amgen Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Amgen Revenue Proportion by Product in 2024

Table 66. Amgen Revenue Proportion by Application in 2024

Table 67. Amgen Revenue Proportion by Geographic Area in 2024

Table 68. Amgen PROTAC Technology SWOT Analysis

Table 69. Amgen Recent Developments

Table 70. Oerth Bio Corporation Information

Table 71. Oerth Bio Description and Major Businesses

Table 72. Oerth Bio Product Features and Attributes

Table 73. Oerth Bio Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Oerth Bio Revenue Proportion by Product in 2024

Table 75. Oerth Bio Revenue Proportion by Application in 2024

Table 76. Oerth Bio Revenue Proportion by Geographic Area in 2024

Table 77. Oerth Bio PROTAC Technology SWOT Analysis

Table 78. Oerth Bio Recent Developments

Table 79. Bayer Corporation Information

Table 80. Bayer Description and Major Businesses

Table 81. Bayer Product Features and Attributes

Table 82. Bayer Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Bayer Recent Developments

Table 84. Kymera Corporation Information

Table 85. Kymera Description and Major Businesses

Table 86. Kymera Product Features and Attributes

Table 87. Kymera Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Kymera Recent Developments

Table 89. Nurix Corporation Information

Table 90. Nurix Description and Major Businesses

Table 91. Nurix Product Features and Attributes

Table 92. Nurix Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Nurix Recent Developments

Table 94. C4 Therapeutics, Inc. Corporation Information

Table 95. C4 Therapeutics, Inc. Description and Major Businesses

Table 96. C4 Therapeutics, Inc. Product Features and Attributes

Table 97. C4 Therapeutics, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. C4 Therapeutics, Inc. Recent Developments

Table 99. Astellas Pharma Inc. Corporation Information

Table 100. Astellas Pharma Inc. Description and Major Businesses

Table 101. Astellas Pharma Inc. Product Features and Attributes

Table 102. Astellas Pharma Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Astellas Pharma Inc. Recent Developments

Table 104. AbbVie Corporation Information

Table 105. AbbVie Description and Major Businesses

Table 106. AbbVie Product Features and Attributes

Table 107. AbbVie Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. AbbVie Recent Developments

Table 109. Kaituo Pharmaceutical Corporation Information

Table 110. Kaituo Pharmaceutical Description and Major Businesses

Table 111. Kaituo Pharmaceutical Product Features and Attributes

Table 112. Kaituo Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Kaituo Pharmaceutical Recent Developments

Table 114. Betta Pharmaceuticals Corporation Information

Table 115. Betta Pharmaceuticals Description and Major Businesses

Table 116. Betta Pharmaceuticals Product Features and Attributes

Table 117. Betta Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. Betta Pharmaceuticals Recent Developments

Table 119. Hengrui Medicine Corporation Information

Table 120. Hengrui Medicine Description and Major Businesses

Table 121. Hengrui Medicine Product Features and Attributes

Table 122. Hengrui Medicine Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Hengrui Medicine Recent Developments

Table 124. BeiGene Corporation Information

Table 125. BeiGene Description and Major Businesses

Table 126. BeiGene Product Features and Attributes

Table 127. BeiGene Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. BeiGene Recent Developments

Table 129. Haichuang Pharmaceutical Corporation Information

Table 130. Haichuang Pharmaceutical Description and Major Businesses

Table 131. Haichuang Pharmaceutical Product Features and Attributes

Table 132. Haichuang Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Haichuang Pharmaceutical Recent Developments

Table 134. East China Pharmaceutical Group Corporation Information

Table 135. East China Pharmaceutical Group Description and Major Businesses

Table 136. East China Pharmaceutical Group Product Features and Attributes

Table 137. East China Pharmaceutical Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. East China Pharmaceutical Group Recent Developments

Table 139. Raw Materials Key Suppliers

Table 140. Distributors List

Table 141. Market Trends and Market Evolution

Table 142. Market Drivers and Opportunities

Table 143. Market Challenges, Risks, and Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. PROTAC Technology Product Picture

Figure 2. Global PROTAC Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Based on CRBN Product Picture

Figure 4. Based on VHL Product Picture

Figure 5. Global PROTAC Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Breast Cancer

Figure 7. Prostate Cancer

Figure 8. Colorectal Cancer

Figure 9. Pancreatic Cancer

Figure 10. Lymphoma

Figure 11. Androgenic Alopecia

Figure 12. Others

Figure 13. PROTAC Technology Report Years Considered

Figure 14. Global PROTAC Technology Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 16. Global PROTAC Technology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 17. Global PROTAC Technology Revenue Market Share by Region (2020-2031)

Figure 18. Global PROTAC Technology Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Based on CRBN Revenue Market Share by Player in 2024

Figure 21. Based on VHL Revenue Market Share by Player in 2024

Figure 22. Global PROTAC Technology Revenue Market Share by Type (2020-2031)

Figure 23. Global PROTAC Technology Revenue Market Share by Application (2020-2031)

Figure 24. North America PROTAC Technology Revenue YoY (2020-2031) & (US$ Million)

Figure 25. North America Top 5 Players PROTAC Technology Revenue (US$ Million) in 2024

Figure 26. North America PROTAC Technology Revenue (US$ Million) by Type (2020 - 2031)

Figure 27. North America PROTAC Technology Revenue (US$ Million) by Application (2020-2031)

Figure 28. US PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 29. Canada PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 30. Mexico PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 31. Europe PROTAC Technology Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Europe Top 5 Players PROTAC Technology Revenue (US$ Million) in 2024

Figure 33. Europe PROTAC Technology Revenue (US$ Million) by Type (2020-2031)

Figure 34. Europe PROTAC Technology Revenue (US$ Million) by Application (2020-2031)

Figure 35. Germany PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 36. France PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 37. U.K. PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 38. Italy PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 39. Russia PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific PROTAC Technology Revenue YoY (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Top 8 Players PROTAC Technology Revenue (US$ Million) in 2024

Figure 42. Asia-Pacific PROTAC Technology Revenue (US$ Million) by Type (2020-2031)

Figure 43. Asia-Pacific PROTAC Technology Revenue (US$ Million) by Application (2020-2031)

Figure 44. Indonesia PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 45. Japan PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 46. South Korea PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 47. Australia PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 48. India PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 49. Indonesia PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 50. Vietnam PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 51. Malaysia PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 52. Philippines PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 53. Singapore PROTAC Technology Revenue (2020-2031) & (US$ Million)

Figure 54. Central and South America PROTAC Technology Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Central and South America Top 5 Players PROTAC Technology Revenue (US$ Million) in 2024

Figure 56. Central and South America PROTAC Technology Revenue (US$ Million) by Type (2020-2031)

Figure 57. Central and South America PROTAC Technology Revenue (US$ Million) by Application (2020-2031)

Figure 58. Brazil PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 59. Argentina PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 60. Middle East and Africa PROTAC Technology Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Top 5 Players PROTAC Technology Revenue (US$ Million) in 2024

Figure 62. South America PROTAC Technology Revenue (US$ Million) by Type (2020-2031)

Figure 63. Middle East and Africa PROTAC Technology Revenue (US$ Million) by Application (2020-2031)

Figure 64. GCC Countries PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 65. Israel PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 66. Egypt PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 67. South Africa PROTAC Technology Revenue (2020-2025) & (US$ Million)

Figure 68. PROTAC Technology Industry Chain Mapping

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Protein Degradation Targeting Chimera PROTAC Market Research Report 2024

Procapil Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Proglumide Market Research Report 2024

Global Protein Expression Technology Market Research Report 2024

Global Procarbazine Drug Market Research Report 2024

Global Protein Expression and Purification Technology Market Research Report 2024

Global PPTA Market Research Report 2024

Global Antimicrobial Technology Market Research Report 2024

Global Cancer Screening Technology Market Research Report 2024

Global Prolene Suture Market Research Report 2025

Global BCC Drug Market Research Report 2024

Global Biochip Products Market Research Report 2024

Global Microfluidic Technology Market Research Report 2024

Global Probiotic Tablet Market Research Report 2024

Global Prolotherapy Market Research Report 2024

Global Biomarker POCT Market Research Report 2024

Global Taurine Surfactant Market Research Report 2025

Global Probiotic Food Market Research Report 2025

Global Pro Microphone Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions